Last $59.05 USD
Change Today -0.83 / -1.39%
Volume 1.2M
TEVA On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
Tel Aviv
Frankfurt
As of 10:03 AM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Meir Heth

Former Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Finance Committee, Teva Pharmaceutical Industries Limited
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 4 different industries.

See Board Relationships
81--

Background*

Prof. Meir Heth was a Professor at the Law School of the College of Management for 15 years. Prof. Heth has an extensive background in business, law and economics. He served at The Bank of Israel since 1962 in various positions, including Senior Economist from 1962 to 1968, Supervisor of Banks from 1969 to 1975 and Senior Advisor to the Governor from 1975 to 1977. Prof. Heth serves as Chairman of Leumi Securities and Investments. He served as Chairman of the Board of ...

Read Full Background

Corporate Headquarters*

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships*

Former Chairman
Former Chairman
Director
1977-N/A
Former Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Finance Committee
1987-N/A
Former Director

Education*

Unknown/Other Education
Hebrew University of Jerusalem
PhD
Hebrew University of Jerusalem
BA
Hebrew University of Jerusalem

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $59.05 USD -0.83

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.